Company Profile
Ligand Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- LGND
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
300.14 USD (-0.80%)
Close
Last updated: August 6, 2026
4.66B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, LGND closed down 0.80% at $300.14. No new same-company headline was identified in the current news window.
Company overview
Business overview
Ligand Pharmaceuticals is a royalty and technology-enabled biopharma company that monetizes its platform through partnered programs, royalties, and biopharma investments.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Ligand sits in specialty biopharma and royalty-driven healthcare.
Business Model Characteristics
The business relies on royalties, milestones, and platform economics rather than a single large commercial franchise.
Position Within the Biotechnology Landscape
Ligand is a unique biotech finance-and-royalty hybrid whose stock often tracks deal flow and royalty visibility.
Future catalysts
Ligand's catalysts are royalty income, portfolio monetization, and capital-allocation updates that show how the company keeps converting assets into cash flow. The story is more about financial engineering than a single drug event.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Ligand Pharmaceuticals (LGND)?
Ligand Pharmaceuticals (LGND) most recently closed at 300.14 USD, a -0.80% move versus the previous session.
What is the market cap of Ligand Pharmaceuticals (LGND)?
Ligand Pharmaceuticals currently has a market capitalization of 4.66B USD on BioPharmSignal.
What does Ligand Pharmaceuticals do?
Ligand Pharmaceuticals is a royalty and technology-enabled biopharma company that monetizes its platform through partnered programs, royalties, and biopharma investments.
On which exchange is LGND stock listed?
Ligand Pharmaceuticals (LGND) is associated with NASDAQ, United States, Biopharma.
What is Ligand?
Ligand's catalysts are royalty income, portfolio monetization, and capital-allocation updates that show how the company keeps converting assets into cash flow.
Which conditions is Ligand Pharmaceuticals targeting with Ligand?
Ligand's catalysts are royalty income, portfolio monetization, and capital-allocation updates that show how the company keeps converting assets into cash flow.
How does Ligand Pharmaceuticals describe recent progress with Ligand?
Ligand's catalysts are royalty income, portfolio monetization, and capital-allocation updates that show how the company keeps converting assets into cash flow.
What is Pharmaceuticals?
Ligand Pharmaceuticals is a royalty and technology-enabled biopharma company that monetizes its platform through partnered programs, royalties, and biopharma investments.